OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenImmigration
  • OpenLobby
  • VaccineWatch
  • OpenSubsidies
  • WarCosts
  • OpenPrescriber

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid · OpenFeds · OpenSpending · OpenImmigration · OpenLobby · VaccineWatch · OpenSubsidies · WarCosts

© 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodology•Download Data
  1. Home
  2. Providers
  3. Specialty Drug Testing, Llc
🔬
Organization

Specialty Drug Testing, Llc

NPI: 1639577091
Monroe, LA
7 years of data
Clinical Laboratory
$29.5M
Total Payments
123.5K
Beneficiaries
158.7K
Services
1.83x
Markup Ratio

Peer Comparison

97th
percentile in specialty
This provider$29.5M
Specialty median$1.9M

📋 Key Findings

1Billed $29.5M over 7 years
21.83x markup ratio
397th percentile in Clinical Laboratory by payments
4Payments surged 1131% in 2018
55 procedures with >3x markup
✓ No flags detected

🔎 Data Analysis

This provider's $29.5M in total Medicare payments ranks in the 97th percentile of Clinical Laboratory providers nationally.

This provider's billing patterns fall within normal ranges for their specialty.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

📈

Notable: Payments increased 1131% in 2018

Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2015$43.78$21.062.08x$22.72$547.1K14.3K6.8K
2016$58.78$18.443.19x$40.34$856.4K27.2K18.7K
2017$91.62$18.964.83x$72.66$849.3K39.0K28.3K
2018$384.77$148.672.59x$236.10$10.5M35.1K29.5K
2019$262.55$174.171.51x$88.38$16.7M38.9K36.5K
2020$69.23$20.423.39x$48.81$135.0K3.9K3.3K
2021$66.67$34.331.94x$32.34$19.9K417338

Top Procedures (20)

81408Molecular pathology procedure level 9
$7.8M
4.0K services$2.0K/svc1.23x markup
81201Gene analysis (adenomatous polyposis coli), full gene sequence
$3.4M
4.5K services$764.40/svc1.79x markup
81317Gene analysis (postmeiotic segregation increased 2 [S cerevisiae]) full sequence analysis
$3.2M
4.8K services$674.61/svc2.03x markup
81298Gene analysis (mutS homolog 6 [E coli]) full sequence analysis
$2.9M
4.5K services$629.01/svc1.45x markup
81295Gene analysis (mutS homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis
$1.7M
4.5K services$374.07/svc1.40x markup
81325Gene analysis (peripheral myelin protein 22), full sequence analysis⚠ 3.1x markup
$1.7M
2.2K services$754.19/svc3.06x markup
81259Gene analysis (alpha globin 1 and alpha globin 2) full sequence analysis
$1.3M
2.3K services$588.00/svc1.25x markup
81406Molecular pathology procedure level 7
$958.1K
3.5K services$277.22/svc1.22x markup
81162Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants
$723.3K
364 services$2.0K/svc1.35x markup
G0481Drug test def 8-14 classes⚠ 3.3x markup
$564.7K
4.2K services$135.72/svc3.31x markup
81211Gene analysis (breast cancer 1 and 2) full sequence and common duplication or deletion variants
$476.6K
203 services$2.3K/svc2.69x markup
81300Gene analysis (mutS homolog 6 [E coli]) duplication or deletion variants
$404.4K
1.7K services$233.24/svc1.22x markup
81319Gene analysis (postmeiotic segregation increased 2 [S cerevisiae]) duplication or deletion variants
$344.2K
1.7K services$199.43/svc1.22x markup
81203Gene analysis (adenomatous polyposis coli), duplication or deletion variants
$339.7K
1.7K services$196.00/svc1.22x markup
80307Testing for presence of drug⚠ 4.3x markup
$284.6K
3.9K services$72.24/svc4.31x markup
G0431Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter
$243.1K
2.5K services$96.88/svc1.55x markup
G0480Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an⚠ 3.8x markup
$217.1K
1.9K services$113.61/svc3.83x markup
G0479Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when⚠ 3.1x markup
$189.0K
2.4K services$77.65/svc3.12x markup
81436Test for detecting genes associated with colon cancer
$187.2K
294 services$636.89/svc1.22x markup
81435Test for detecting genes associated with colon cancer
$176.4K
277 services$636.89/svc1.22x markup
Show detailed table ▾
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
81408Molecular pathology procedure level 94.0K$7.8M$2.0K1.23x
81201Gene analysis (adenomatous polyposis coli), full gene sequence4.5K$3.4M$764.401.79x
81317Gene analysis (postmeiotic segregation increased 2 [S cerevisiae]) full sequence analysis4.8K$3.2M$674.612.03x
81298Gene analysis (mutS homolog 6 [E coli]) full sequence analysis4.5K$2.9M$629.011.45x
81295Gene analysis (mutS homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis4.5K$1.7M$374.071.40x
81325Gene analysis (peripheral myelin protein 22), full sequence analysis2.2K$1.7M$754.193.06x
81259Gene analysis (alpha globin 1 and alpha globin 2) full sequence analysis2.3K$1.3M$588.001.25x
81406Molecular pathology procedure level 73.5K$958.1K$277.221.22x
81162Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants364$723.3K$2.0K1.35x
G0481Drug test def 8-14 classes4.2K$564.7K$135.723.31x
81211Gene analysis (breast cancer 1 and 2) full sequence and common duplication or deletion variants203$476.6K$2.3K2.69x
81300Gene analysis (mutS homolog 6 [E coli]) duplication or deletion variants1.7K$404.4K$233.241.22x
81319Gene analysis (postmeiotic segregation increased 2 [S cerevisiae]) duplication or deletion variants1.7K$344.2K$199.431.22x
81203Gene analysis (adenomatous polyposis coli), duplication or deletion variants1.7K$339.7K$196.001.22x
80307Testing for presence of drug3.9K$284.6K$72.244.31x
G0431Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter2.5K$243.1K$96.881.55x
G0480Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an1.9K$217.1K$113.613.83x
G0479Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when2.4K$189.0K$77.653.12x
81436Test for detecting genes associated with colon cancer294$187.2K$636.891.22x
81435Test for detecting genes associated with colon cancer277$176.4K$636.891.22x

Markup Analysis

Charge-to-Payment Ratio

1.83x

This provider submits charges 1.83 times higher than what Medicare actually pays.

What This Means

A markup ratio of 1.83x means for every $100 Medicare pays, this provider initially charges $183. This is lower than the national average.

Location

Monroe, LA

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Related

Browse
← Back to Provider Directory
State
All providers in LA →
Specialty
All Clinical Laboratory providers →
Tool
Compare this provider →
Analysis
Fraud Watchlist →
Search
Search all providers →

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • • Centers for Medicare & Medicaid Services (CMS)
  • • Medicare Provider Utilization and Payment Data (2014-2023)
  • • National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data